Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / diagnosis*
  • Adrenal Gland Neoplasms / pathology
  • Adrenal Gland Neoplasms / therapy
  • Adrenalectomy
  • Adrenocortical Carcinoma / diagnosis*
  • Adrenocortical Carcinoma / secondary
  • Adrenocortical Carcinoma / therapy
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemoradiotherapy, Adjuvant
  • Humans
  • Mitotane / therapeutic use
  • Neoplasm Staging
  • Neoplasms, Hormone-Dependent / diagnosis*
  • Neoplasms, Hormone-Dependent / pathology
  • Neoplasms, Hormone-Dependent / therapy
  • Pheochromocytoma / diagnosis*
  • Pheochromocytoma / secondary
  • Pheochromocytoma / therapy
  • Risk Assessment

Substances

  • Antineoplastic Agents, Hormonal
  • Mitotane